Publications by authors named "Michael Scherbakov"

Claim this Profile
C
Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective study.
Lilia Ben Debba, Dominique Derreumaux, Germain Lonnet, Laura Taddei, Michael Scherbakov

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence of Skin and Soft Tissue Infections in the United States and Associated Healthcare Utilization Between 2010 and 2020.
Venanzio Vella, Dominique Derreumaux, Emmanuel Aris, Michele Pellegrini, Mario Contorni, Michael Scherbakov

Open Forum Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media.
Patricia Izurieta, Michael Scherbakov, Javier Nieto Guevara, Volker Vetter, Lamine Soumahoro

Hum Vaccin Immunother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.
Leyla Namazova-Baranova, Md Ahsan Habib, Michael Povey, Kamilla Efendieva, Olga Fedorova, Michael Scherbakov

Hum Vaccin Immunother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.
Asmik Asatryan, Nadia Meyer, Michael Scherbakov, Victor Romanenko, Irina Osipova

Hum Vaccin Immunother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underlying factors in paediatric invasive pneumococcal disease in Belgium.
Patricia Izurieta, Michael Scherbakov, Volker Vetter

Lancet Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.
Victor Romanenko, Irina Osipova, Anna Galustyan, Michael Scherbakov, Nathalie Baudson

Hum Vaccin Immunother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis